Pharmaceuticals | Change of Control Agreements | Business Contracts

First Amendment to the Theravance Biopharma, Inc. Change in Control Severance Plan (Theravance Biopharma, Inc., Filed With SEC on November 9, 2022)

Executive Change in Control and Severance Plan (Ventyx Biosciences, Inc., Filed With SEC on May 9, 2022)

Change in Control and Severance Agreement between the Registrant and Kevin Church (Athira Pharma, Inc., Filed With SEC on March 28, 2022)

Severance and Change in Control Agreement by and between Corcept Therapeutics Incorporated and William Guyer, dated February 9, 2022 (Corcept Therapeutics Incorporated, Filed With SEC on February 15, 2022)

Amended and Restated Change in Control and Severance Agreement between the Company and Mark Litton, Ph.D (Athira Pharma, Inc., Filed With SEC on January 31, 2022)

Change in Control Severance Agreement between Alimera Sciences, Inc., and Philip J. Ashman, Ph.D. as of July 16, 2021 (ALIMERA SCIENCES INC, Filed With SEC on November 5, 2021)

Form of Change in Control and Severance Agreement (DiCE MOLECULES HOLDINGS, LLC, Filed With SEC on September 9, 2021)

Change in Control and Severance Agreement between the Registrant and Rachel Lenington (Athira Pharma, Inc., Filed With SEC on August 16, 2021)

Change in Control and Severance Agreement between the Registrant and Mark Worthington (Athira Pharma, Inc., Filed With SEC on August 16, 2021)

Verona Pharma plc Employee Change in Control Severance Benefit Plan (Verona Pharma plc, Filed With SEC on August 11, 2021)

Pharmaceuticals (45) | Change of Control Agreements (45)